Metabolomic profiling in kidney cells treated with a sodium glucose-cotransporter 2 inhibitor
Abstract We aimed to determine the metabolomic profile of kidney cells under high glucose conditions and following sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment. Targeted metabolomics using the Absolute IDQ-p180 kit was applied to quantify metabolites in kidney cells stimulated with hig...
Main Authors: | Hyung Ah Jo, Jong-Hyun Seo, Sunhwa Lee, Mi-yeon Yu, Eunjin Bae, Dong Ki Kim, Yon Su Kim, Da Jung Kim, Seung Hee Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-28850-3 |
Similar Items
-
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
by: Nam Hoon Kim, et al.
Published: (2022-07-01) -
Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations
by: Kyoung Hwa Ha, et al.
Published: (2024-03-01) -
Use of Sodium–glucose Cotransporter 2 Inhibitors in Patients with Chronic Kidney Disease
by: Ahmed M Alkhunaizi, et al.
Published: (2023-01-01) -
Sodium‐glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease
by: Shingo Kato, et al.
Published: (2022-10-01) -
Effects of Sodium-Glucose Cotransporter-2 Inhibitors and Thiazolidinedione on New-Onset Atrial Fibrillation Risk to Patients with Type 2 Diabetes
by: Haegeun Song, et al.
Published: (2022-09-01)